Work

A new look at old problems: Ovarian function suppression in the real world

Year: 2021

Type: article

Abstract: There is concern that the addition of ovarian function suppression to the endocrine treatment of premenopausal patients with breast cancer will increase nonadherence to treatment in this population. Although nonadherence to oral endocrine therapy was fairly high in the first year in this study, it was not worse when it was combined with endocrine therapy.

Source: Cancer

DOI: 10.1002/cncr.33368

Authors: Tal Sella, Ann H. Partridge

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: American Physicians Fellowship for Medicine in Israel